3 YEAR
Brookes is also the foremost national company to have 4 international certifications including ISO-9001, ISO-14001, ISO-17025, OHSAS-18001 certifications. Apart from maintaining a world class standard of quality in operations, Brookes has continually been expanding its portfolio with timely introduction of new molecules. It was the year 1996 when our licensed product Hepa Merz became brand leader in liver disease segment. In the year 2000, pain and inflammatory remedy Phlogin got listed among top 100 brands of Pakistan. The following year, in 2001, Brookes launched a whole range of highly sensitive Anesthesia products. Again in 2002, Brookes flagship product Pyodine became brand leader in antiseptic market. Brookes Erdosteine became the second biggest brand in COPD/OB segment in 2004. Today, we are proud to hold our market leadership position in more than half the products we market.
Read More
